These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7980959)
1. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats. Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ Bone; 1994; 15(5):489-96. PubMed ID: 7980959 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats. Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060 [TBL] [Abstract][Full Text] [Related]
3. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats. Jee WS; Lin BY; Ma YF; Ke HZ J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321 [TBL] [Abstract][Full Text] [Related]
4. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats. Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930 [TBL] [Abstract][Full Text] [Related]
5. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats. Li QN; Jee WS; Ma YF; Ke HZ; Xie H; Huang LF; Liang NC Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926 [TBL] [Abstract][Full Text] [Related]
6. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats. Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244 [TBL] [Abstract][Full Text] [Related]
7. Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. Ma Y; Chen YY; Jee WS; Ke HZ; Ijiri K Bone; 1995 Oct; 17(4 Suppl):267S-272S. PubMed ID: 8579927 [TBL] [Abstract][Full Text] [Related]
8. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618 [TBL] [Abstract][Full Text] [Related]
9. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats. Pan Z; Jee WS; Ma YF; McOsker JE; Li XJ Bone; 1995 Oct; 17(4 Suppl):291S-296S. PubMed ID: 8579931 [TBL] [Abstract][Full Text] [Related]
10. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats. Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906 [TBL] [Abstract][Full Text] [Related]
11. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: dynamic histomorphometry of changes in bone mass. Jee WS; Tang L; Ke HZ; Setterberg RB; Kimmel DB Bone; 1993; 14(3):493-8. PubMed ID: 8363898 [TBL] [Abstract][Full Text] [Related]
12. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat. Ito H; Ke HZ; Jee WS; Sakou T Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921 [TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439 [TBL] [Abstract][Full Text] [Related]
14. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats. Liang HH; Ma YF; Jee WS; Pan Z; Setterberg RB; McOsker JE; Li XJ Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936 [TBL] [Abstract][Full Text] [Related]
15. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats. Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950 [TBL] [Abstract][Full Text] [Related]
16. Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy. Boyce RW; Wronski TJ; Ebert DC; Stevens ML; Paddock CL; Youngs TA; Gundersen HJ Bone; 1995 Feb; 16(2):209-13. PubMed ID: 7756049 [TBL] [Abstract][Full Text] [Related]
17. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure. Tang LY; Jee WS; Ke HZ; Kimmel DB J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502 [TBL] [Abstract][Full Text] [Related]
18. Skeletal effects of constant and terminated use of sodium risedronate in ovariectomized rats. Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):160-3. PubMed ID: 10374643 [TBL] [Abstract][Full Text] [Related]
19. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Baumann BD; Wronski TJ Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]